C100 AB (publ) (XSAT:C100)
3.040
0.00 (0.00%)
At close: Sep 15, 2026
C100 AB Revenue
C100 AB had revenue of 3.00M SEK in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 2.55M, down -53.22% year-over-year. In the year 2025, C100 AB had annual revenue of 3.30M, down -1.20%.
Revenue (ttm)
2.55M
Revenue Growth
-53.22%
P/S Ratio
-101.06
Revenue / Employee
-19.40K
Employees
1
Market Cap
9.80M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.30M | -40.12K | -1.20% |
| Dec 31, 2024 | 3.34M | 2.20M | 193.09% |
| Dec 31, 2023 | 1.14M | -2.19M | -65.79% |
| Dec 31, 2022 | 3.33M | -2.24M | -40.17% |
| Dec 31, 2021 | 5.57M | -974.24K | -14.89% |
| Dec 31, 2020 | 6.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Exalt AB | 42.45M |
| Risk Intelligence | 39.63M |
| Windon Energy Group AB | 14.24M |
| Tessin Nordic Holding AB | 11.09M |
| Inhalation Sciences Sweden AB | 8.30M |
| Monivent AB | 1.15M |
| Biofrigas Sweden AB | 748.71K |
C100 AB News
- 16 days ago - C100 AB Quarterly report: Q2 2026 - Filings
- 4 months ago - C100 AB Quarterly report: Q1 2026 - Filings
- 7 months ago - C100 AB Quarterly report: Q4 2025 - Filings
- 7 months ago - C100 AB Annual report: Q4 2025 - Filings
- 11 months ago - C100 AB Quarterly report: Q3 2025 - Filings